Plain-English translation of NCT07504367 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether artificial intelligence tools can help doctors write better cancer treatment recommendations. Researchers will compare two groups of junior doctors: one group using AI assistance to help draft treatment plans, and another group using traditional research methods like textbooks and online searches. The goal is to see if AI can improve the quality and speed of cancer treatment planning.
Cancer treatment decisions work best when multiple specialists collaborate together, but this process is time-consuming and not always available to all patients. This trial explores whether this treatment approach can be made faster and more accurate with AI assistance, potentially helping more patients receive personalized care.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to either the AI-assisted group or the traditional research group. You'll be asked to write treatment recommendations for cancer patients using your assigned method. In the AI group, you'll input patient information into an artificial intelligence tool and use its suggestions as reference material while making your own final clinical decisions. Expert reviewers will then evaluate and score all the treatment plans using a standardized scale to compare quality and efficiency between the two approaches.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China